slides_product_dr chen_100320_2010_road+show_e (rev 03).pptx
TRANSCRIPT
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
1/30
Preview : Yung KienGanoderma 2
Deng-Hai Chen
Shuang Hor Group BTRI
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
2/30
The Motive & Objective of
Research & Development
Motive : Meeting customer expectationto reduce the amount of consumption.
How to reduce the amount of
consumption and yet maintain theefficacy?
The need for compositional realignment.
The only approach : To develop a product
with extremely high content of theeffective constituent - triterpenoids
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
3/30
Effective Constituents of Lingzhi
Species Type Ganoderma tsugae Ganoderma lucidum
Triterpenoids Ganoderic acids, ganoderiol,
ganodone, and ganoaldehyde
Lucidenic acids, lucideriol, lucidon
and lucialdehyde.
Polysaccharides (peptides) Macro molecular polysaccharides
(peptides), hetero glucan, glucan
peptides, hetero glucan peptides
Macro molecular polysaccharides
(peptides), hetero glucan, glucan
peptides, hetero glucan peptides
Plant Steroids Ergosterol-moiety sterols and
lanosterol-moiety sterols.
Ergosterol-moiety sterols and
lanosterol-moiety sterols.
Nucleotides Uridine, guanine, and adenosine. Uridine, guanine and adenosine.
Polypeptides Micro molecular protein LZ-8 Micro molecular protein LZ-8
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
4/30
Uniqueness of the Effective Constituents
Types of Effective
Constituents
Num
ber
Uniqueness Explanation
Triterpenoid ganoderic
(lucidenic) acids
~200 Yes Only found in ganoderma
Polysaccharides (peptides) >100 Nil Also found in shiitake mushroom,needle mushroom, etc.
Plant Sterols >20 Nil Also found in mushroom and other
plants.
Nucleotides ~5 Nil Also found in mushrooms and other
vegetables.
Polypeptides ~10 Nil Also found in shiitake mushroom and
needle mushroom
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
5/30
Pharmacological Actions of Triterpenoid
Ganoderic (Lucidenic) Acids
Type of Effective
constituents
Pharmacological Actions
Triterpenoid Ganoderic
(Lucideric) Acids
Immune modulation, liver protection, anti-free
radicals (delay ageing), improves the condition ofallergic physical constitution, regulates blood
sugar, subdues tumour growth (anti-cancer),
reduces blood lipids, bring down blood pressure,
inhibits (HIV) viruses growth, anti-inflammation,
helps prevent prostate enlargement, enhances
learning ability, and improves memory.
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
6/30
The key determinants are ganoderic (lucideric) acids, to
be followed by polysaccharides (peptides) and then
neucleotides.
Both Japan Health Food Authorization (JHFA) andTaiwan Functional Food GMP take ganoderic (lucideric
acids as the determining benchmark.
The low content and difficulty in isolating of ganoderic
(lucideric) acids explain why research works on themwas much lesser than on polysaccharides.
Differentiating the Good Quality
Lingzhi from Others
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
7/30
Lin Zhi Bingof Peking University Health Science Centre, China
Hattori Masao of Japan.
Xiao Ming Xiof National Yang Ming University, Taiwan
Su Qing Hua of Taipei Medical University. Lin Yun Lian of National Research Institute of Chinese Medicine
Taiwan.
Lin Shu Pin of National Taiwan University, College of Medicine,
Taiwan
Yan Guo Qin of National Chung Hsing University, Taiwan
Prominent Lingzhi Researches
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
8/30
It all began in the 1970s. Mostly on the research of
polysaccharides, as they were much easier to isolate
and featured a high content.
The research on triterpenoids, such as ganoderic(lucideric) acides, began only in the 1980s, because
they are trace components and difficult to isolate.
Due to the success in artificial cultivation, more than 20
types of triterpenoids, including ganoderic and lucidericacids, have since then been discovered.
The History of Modern Research Works
on Ganoderma Effective Constituents
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
9/30
By the 2000s, the gap in the number of researcharticles between triterpenoids and polysaccharides hasnarrowed substantially
Towards the end of 2005 and beyond, there has beenan increasingly bigger number of research papers ontriterpenoids, mostly pertaining to anti-cancerexperiments.
It has been revealed that triterpenoids exhibit direct
pharmacological actions, while those of polysaccharideare mostly indirect.
Polysaccharides and Triterpenoids
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
10/30
Polysaccharides: Diversity is essential, but the
consumption amount needs not to be high
(higher than 3g), as the pharmacological action
are indirect.
Triterpenoids: Diversity is also essential, but fo
particular individuals, high consumption amounts
are needed in order to show efficacy.
The Effective Constituents of Lingzhi
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
11/30
The Processing Involved in Developing a
Natural Drug
An efficacious
natural substancesWhat sort of efficacy?
Development of effective
Constituents/crude drug
What are the effective
Constituents?
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
12/30
Lovastatin : A hypolipidemic drug for reducing blood lipids,
purified from red yeast rice (Monascus app).
Silymarin : A hapatinica drug for liver protection, purified from the
seed of milk thistle (Silybum marianum).
Colchicine : A hyperuricemia drug for the treatment of gout,
purified from the bulb of autumn crocus (Colchicum antumnale).
Taxol : An anti-cancer drug for subduing cancer growth, purified
from the bark of ground hemlock (Taxus brevifolia).
To achieve high potency, it is essential to purify the effectivecomponents from raw materials.
Some Notable Natural Drugs
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
13/30
Developing medicinal drugs that are free from side effects.
Extraction from natural substances stands the greatest chance oachieving this objective.
Most of the medicine available today are known to exhibit side
effects. Ganoderma : Contains ganoderic (lucideric) acids, making it the
most potential to be developed into efficacious healthcareproducts that are safe for long-term consumption.
Shuang Hor is the only enterprise having the worlds most
resourceful background to develop ganoderma triterpenoids asthe natural drugs
The Ultimate Objective of Western
Medicines
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
14/30
The New Milestone of Ganoderma Bio-
tecnology: Purification & Mass-production
Purification is different from Extraction & Concentration
Extraction/
concentration Purification
Raw Ganoderma (the content of 9Ganoderic acids: ~0.2%)
Triterpenoids
100%triterpenoids(the content of 9ganoderic acidsexceeds 50%)
Ganodermaproducts (the
content of 9ganoderic(lucideric) acids:2~9%)
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
15/30
Progress Made in Purification Techniques
Mass production of Ganoderma triterpenoidsbecame feasible.
In 2008, the content of 9 types of ganoderic (lucideric)acids was purified to exceeding 50%.
In 2009, pilot-production became a success withtechnology transfer to Yung Kien Plant. Shuang Hor is the worlds first enterprise to embark
on the mass-production of Ganoderma triterpenoids. The first setp to bio-tech pharmaceutical production :
Purification & mass-production. The purification facilities and techniquest are kept as
a top trade secret.
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
16/30
Patent Pending for Yung Kien Ganoderma 2
The patent for the production process is nowunder application. Patent application numbersare 98102308 and PI20090273 for Taiwan &
Malaysia respectively GANODERMA EXTRACT WITH HIGH
AMOUNTS OF GANODERIC (LUCIDERIC)ACIDS AND METHOD FOR PRODUCING THESAME
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
17/30
Yung Kien Ganoderma 2 and its Raw
Ingredient
YK-01 only, but should be carefully selected.
Only the fruiting bodies cultured by computerizedhi-tech greenhouse, and harvested with
professional screening. Only those with high amounts of ganoderic acids
are accepted for production.
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
18/30
Yung Kien Ganoderma 2 and its Process
With the inclusion of purified YK-1 triterpenoids, itscontent of 9 types of ganoderic acids has increased to12% and above.
Retention of the effective constituents of Yung KienGanoderma.
Purification -> Mixing with Yung Kien Ganoderma ->Freeze Drying (Lyophilization) -> Filling
Retention of the effective constituents and safety ofYung Kien Ganoderma, giving an upgraded productwith rich content of triterpenoids.
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
19/30
Yung Kien Ganoderma 2
An innovation ofGanoderma productby the combination ofagricultural bio-technology and bio-chemistry purificationtechniques.
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
20/30
9 Ganoderic Acids (A, B, C, etc) and Their
Average Contents
6 capsules reduced to 1, which means a 6-fold increase of thecontent of the 9 ganoderic acids.
Yung KienGanoderma
Yung KienGanoderma 2
2% 12%
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
21/30
Who Can Benefit From Yung Kien
Ganoderma 2
People who are unable to consume large doses(more than 20 capsules a day) and in need of largeamounts of ganoderic acids.
Patients of autoimmune diseases: asthma, allergies,lupus erythematosus, rheumatoid arthritis,myasthenia gravis, psoriasis, etc.
People who suffer viral hepatitis and liver fibrosis.
People who underwent organ transplantation.
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
22/30
Testimonial : Psoriasis (a disorder
characterised by dry, scaly skin)
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
23/30
Psoriasis (a disorder characterised by dry,
scaly skin)
Causative factors : Auto-antibodies produced by white bloodcells attack the outer layer of the skin. It is an auto-immunedisease.
Conventional treatment: The use of powerful steroids.
Symptoms were first observed in 1996 and the cause wassuccessfully diagnosed only 3 years later (1999).
Underwent treatment during 2000-2002, involving oral intakeand topical application of steroid formulations. Apart fromgiving rise to side effect such as moon face, joint pain,
lethargy, and pain while urinating, the treatment was noteffective.
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
24/30
Psoriasis (a disorder characterised by dry,
scaly skin) with Ganoderma
In 2002, began the consumption of Botanical Lingzhi (40% lingzhi + 60%pollen)
With the consumption gradually increased from the initial 10 capsules to 30capsules a day, improvement result was observed 3 month later. Followingthe disappearance of the silvery scales, the consumption was reduced to
10 capsules a day. In March 2006, the condition recurred due to physical exhaustion.
Switched to the consumption of Yung Kien Ganoderma, 20 capsules a dayfor 50 days.
Experienced strong vertigo reaction and become bedridden for 2 weeks.
Causative factor of the onset :Sensitivity to low temperature.
Upon recovery, the patient has been able to join in the oversea tour to Mt.Fuji, Japan.
Wh C B fi f Y Ki
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
25/30
Who Can Benefit from Yung Kien
Ganoderma 2
An adjuvant for AIDS patients undergoing medication
An adjuvant for patients of cancerous diseases:Leukemia, liver cancer, prostate cancer, colon cancer
For other cancerous diseases, the consumption ofYung Kien Ganoderma can be reduced.
Both Yung Kien Ganoderma and Yung KienGanoderma 2 can be taken together to get asynergistic healing effect.
T ti Li Ci h i ith
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
26/30
Testimony : Liver Cirrhosis with
Complication of Liver Tumour
Suffered from liver fibrosis in 1999at age 34, caused by hepatitis C.
In 2003, began the consumption ofYung Kien Ganoderma, 12capsules a day. Reduced to 4
capsules a day 3 months later,thinking that full recovery has beenachieved.
Experienced recurrence in 2005,complicated with liver tumour.Began consuming 30 capsules of
Yung Kien Ganoderma a day for 7months.
T ti Li Ci h i ith
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
27/30
Testimony : Liver Cirrhosis with
Complication of Liver Tumour (contd)
By March 2007, liver functions restored normal. Thetumour disappeared and fibrosis was gone. HepatitisC virus still detected. Continued with the consumptionof 20 capsules a day.
By December 2007, hepatitis C virus tested negative,with the body producing the needed antibodies.
Attributing factors : 1) Had faith in Shuang Hor andGanoderma. 2) Regained optimal health through
long-term consumption in large doses (30 capsules aday).
Y Ki G d d Y Ki
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
28/30
Yung Kien Ganoderma and Yung Kien
Ganoderma 2
Yung Kien Ganoderma 2 is for people with specialneeds, while Yung Kien Ganoderma is for ordinarypeople.
Yung Kien Ganoderma is a Health Food, hence canbe consumed by everybody
For the purpose of everyday health maintenance,Yung Kien Ganoderma is good enough.
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
29/30
Application of Yung Kien Ganoderma 2
Health FoodYung Kien Ganoderma 2
21st C t th C t f G d
-
7/28/2019 Slides_Product_Dr Chen_100320_2010_Road+Show_E (Rev 03).pptx
30/30
21st Century, the Century of Ganoderma
Bio-technology
Patent owners of core technologies are destined tobe the market leaders.
Different effective constituents inherently cater todifferent targeted health-care attributes.
On-going development of newer alternative productsto give similar efficacy at smaller doses.
Ganoderma triterpenoids show the most numerousefficacies, thus posses the greatest potential tobecome medicines without any side effects.